Cargando…

Therapeutic Effect of Cabazitaxel and Blood-Brain Barrier opening in a Patient-Derived Glioblastoma Model

Treatment of glioblastoma and other diseases in the brain is especially challenging due to the blood-brain barrier, which effectively protects the brain parenchyma. In this study we show for the first time that cabazitaxel, a semi-synthetic derivative of docetaxel can cross the blood-brain barrier a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sulheim, Einar, Mørch, Yrr, Snipstad, Sofie, Borgos, Sven Even, Miletic, Hrvoje, Bjerkvig, Rolf, Davies, Catharina de Lange, Åslund, Andreas K.O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427936/ https://www.ncbi.nlm.nih.gov/pubmed/30899638 http://dx.doi.org/10.7150/ntno.31479

Ejemplares similares

Ultrasound-mediated delivery and distribution of polymeric nanoparticles in the normal brain parenchyma of a metastatic brain tumour model
por: Baghirov, Habib, et al.
Publicado: (2018)

Contact-mediated intracellular delivery of hydrophobic drugs from polymeric nanoparticles
por: Snipstad, Sofie, et al.
Publicado: (2014)

Erratum to: Contact-mediated intracellular delivery of hydrophobic drugs from polymeric nanoparticles
por: Snipstad, Sofie, et al.
Publicado: (2015)

Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles
por: Sulheim, Einar, et al.
Publicado: (2016)

Sonoporation Using Nanoparticle-Loaded Microbubbles Increases Cellular Uptake of Nanoparticles Compared to Co-Incubation of Nanoparticles and Microbubbles
por: Snipstad, Sofie, et al.
Publicado: (2021)

Identification of novel cyanoacrylate monomers for use in nanoparticle drug delivery systems prepared by miniemulsion polymerisation – A multistep screening approach
por: Hyldbakk, Astrid, et al.
Publicado: (2022)

Efficient Enhancement of Blood-Brain Barrier Permeability Using Acoustic Cluster Therapy (ACT)
por: Åslund, Andreas K.O., et al.
Publicado: (2017)

Characterization of immune cell populations in syngeneic murine tumor models
por: Snipstad, Sofie, et al.
Publicado: (2023)

Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression
por: Huszthy, Peter C., et al.
Publicado: (2015)

Correction: Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression
por: Huszthy, Peter C., et al.
Publicado: (2015)

A comparative biodistribution study of polymeric and lipid-based nanoparticles
por: Åslund, Andreas K. O., et al.
Publicado: (2022)

Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
por: Pandya, Abhilash D., et al.
Publicado: (2021)

Contrast Enhanced Magnetic Resonance Imaging of Amyloid-β Plaques in a Murine Alzheimer’s Disease Model
por: Sulheim, Einar, et al.
Publicado: (2023)

Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells
por: Podergajs, Neža, et al.
Publicado: (2015)

Remission of Invasive, Cancer Stem-Like Glioblastoma Xenografts Using Lentiviral Vector-Mediated Suicide Gene Therapy
por: Huszthy, Peter C., et al.
Publicado: (2009)

Expansive growth of two glioblastoma stem-like cell lines is mediated by bFGF and not by EGF
por: Podergajs, Neza, et al.
Publicado: (2013)

Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects
por: Hossain, Jubayer A, et al.
Publicado: (2020)

A reproducible brain tumour model established from human glioblastoma biopsies
por: Wang, Jian, et al.
Publicado: (2009)

Cytotoxicity of Poly(Alkyl Cyanoacrylate) Nanoparticles
por: Sulheim, Einar, et al.
Publicado: (2017)

Alginate Microsphere Encapsulation of Drug-Loaded Nanoparticles: A Novel Strategy for Intraperitoneal Drug Delivery
por: Fleten, Karianne Giller, et al.
Publicado: (2022)

Preclinical profile of cabazitaxel
por: Vrignaud, Patricia, et al.
Publicado: (2014)

PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
por: Ji, Jianxiong, et al.
Publicado: (2019)

Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy
por: Zhu, Huaiyang, et al.
Publicado: (2017)

Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma
por: Han, Mingzhi, et al.
Publicado: (2019)

Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling
por: Han, Mingzhi, et al.
Publicado: (2020)

Deciphering the complex role of thrombospondin-1 in glioblastoma development
por: Daubon, Thomas, et al.
Publicado: (2019)

The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells
por: Atzori, Maria Grazia, et al.
Publicado: (2017)

iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype
por: Rajcevic, Uros, et al.
Publicado: (2009)

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
por: Fack, Fred, et al.
Publicado: (2014)

Feasibility of cabazitaxel in octogenarian prostate cancer patients
por: Tralongo, Paolo, et al.
Publicado: (2023)

Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
por: Bougnaud, Sébastien, et al.
Publicado: (2016)

OTME-14. TGF-beta signaling in microtube formation of glioblastoma
por: Storevik, Simon, et al.
Publicado: (2021)

In vivo models of primary brain tumors: pitfalls and perspectives
por: Huszthy, Peter C., et al.
Publicado: (2012)

Critical appraisal of cabazitaxel in the management of advanced prostate cancer
por: Pal, Sumanta Kumar, et al.
Publicado: (2010)

Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors
por: Ferron, Géraldine M., et al.
Publicado: (2013)

Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
por: Minnema, Jordi, et al.
Publicado: (2022)

Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03
por: Fayette, Jerome, et al.
Publicado: (2017)

THER-11. PEPTIDE-MEDIATED PERMEABILIZATION OF THE BLOOD-BRAIN BARRIER IMPROVES DRUG DELIVERY TO BRAIN METASTASIS
por: Aasen, Synnøve Nymark, et al.
Publicado: (2019)

Glutamine Synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma
por: Tardito, Saverio, et al.
Publicado: (2015)

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_htbng1dis1r5hbi5brmit47qta